Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 8/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | MAT2A | P31153 | 4/20 | 0.32 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | ICMT | O60725 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19953880 | 0.90 | KIF11 (0.37) | KIF11HSD11B1TRPV1SCN5ANOTUM | |
| SCHEMBL21116899 | 0.89 | KIF11 (0.44) | KIF11MAT2ANOTUM | |
| SCHEMBL10090573 | 0.86 | KIF11 (0.40) | KIF11HSD11B1 | |
| SCHEMBL21116268 | 0.86 | KIF11 (0.40) | KIF11HSD11B1 | |
| SCHEMBL21116255 | 0.85 | KIF11 (0.39) | KIF11 | |
| SCHEMBL23798850 | 0.85 | KIF11 (0.39) | KIF11 | |
| SCHEMBL21116535 | 0.83 | KIF11 (0.52) | KIF11MAT2A | |
| SCHEMBL21116518 | 0.82 | AR (0.39) | KIF11HSD11B1NOTUM | |
| SCHEMBL10090543 | 0.81 | KIF11 (0.36) | KIF11HSD11B1 | |
| SCHEMBL21116284 | 0.81 | RXRA (0.37) | KIF11NOTUMICMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190194130-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NOX3, ORC3 | KIF11 3544/4885HSD11B1 1293/4885TRPV1 3267/4885 |
| US-11136294-B2 | Organic molecules for use in optoelectronic devices | OR10J3, ORC3, NOX3 | KIF11 3520/4885HSD11B1 1242/4885TRPV1 3271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.